Senior insider sale
Chief Scientific Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$13.6K
15.02K shares
What this filing means
TAVERAS ARTHUR plans to sell 15.02K shares of X4 PHARMACEUTICALS, INC valued at approximately $13.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2024ACC: 0001973141-24-000169
Officer· Chief Scientific Officer
Since Nov 2020
15.02K
Shares to sell
$13.6K
Approx. market value
14.23K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Award
N/A
3/10/2024
14.23KTotal acquired14.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2024 | Stock Award N/A | 14.23K | — |
| Total | 14.23K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
787.00
Market value
$792.67
2/12/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.23K
Market value
$12.8K
3/11/2024
Total
Units
15.02K
Value
$13.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/12/2024 | 787.00 | $792.67 | — | Completed |
| Planned — Approximate Date | ||||
3/11/2024 | 14.23K | $12.8K | NASDAQ | Planned |
| Total | 15.02K | $13.6K | ||